肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae):治療薬開発パイプライン動向2015

◆英語タイトル:Skin And Skin Structure Infections by S.Pneumoniae-Pipeline Insights, 2015
◆商品コード:DELVP501653
◆発行会社(リサーチ会社):DelveInsight
◆発行日:2015年版(※最新版はお問い合わせください)
◆ページ数:60以上
◆レポート形式:英語 / PDF
◆納品方法:Eメール(納品まで約3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、世界における肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae)の概要

・肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae)治療薬開発に取り組んでいる企業リスト

・図表一覧
【レポートの概要】

SUMMARY
DelveInsight’s,“ Skin And Skin Structure Infections by S.Pneumoniae-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Skin And Skin Structure Infections by S.Pneumoniae. This report provides information on the therapeutic development based on the Skin And Skin Structure Infections by S.Pneumoniae dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Skin And Skin Structure Infections by S.Pneumoniae
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Skin And Skin Structure Infections by S.Pneumoniae pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Skin And Skin Structure Infections by S.Pneumoniae and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


【レポートの目次】

Table of Contents
• Skin And Skin Structure Infections by S.Pneumoniae Overview
• Skin And Skin Structure Infections by S.Pneumoniae Pipeline Therapeutics
• Skin And Skin Structure Infections by S.Pneumoniae Therapeutics under Development by Companies
• Skin And Skin Structure Infections by S.Pneumoniae Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Skin And Skin Structure Infections by S.Pneumoniae Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Skin And Skin Structure Infections by S.Pneumoniae Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Skin And Skin Structure Infections by S.Pneumoniae Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Skin And Skin Structure Infections by S.Pneumoniae – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Skin And Skin Structure Infections by S.Pneumoniae – Discontinued Products
• Skin And Skin Structure Infections by S.Pneumoniae – Dormant Products
• Companies Involved in Therapeutics Development for Skin And Skin Structure Infections by S.Pneumoniae
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Skin And Skin Structure Infections by S.Pneumoniae, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Monotherapy Products
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Combination Products
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Route of Administration
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Stage and Route of Administration
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Molecule Type
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Stage and Molecule Type
• Skin And Skin Structure Infections by S.Pneumoniae Therapeutics – Discontinued Products
• Skin And Skin Structure Infections by S.Pneumoniae Therapeutics – Dormant Products
• Products under Development by Companies, 2015


List of Figures
• Number of Products under Development for Skin And Skin Structure Infections by S.Pneumoniae, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Monotherapy Products
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Combination Products
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Route of Administration
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Stage and Route of Administration
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Molecule Type
• Skin And Skin Structure Infections by S.Pneumoniae Assessment by Stage and Molecule Type


【レポートのキーワード】

肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 肺炎球菌による皮膚および皮膚構造感染症(Skin And Skin Structure Infections by S.Pneumoniae):治療薬開発パイプライン動向2015(Skin And Skin Structure Infections by S.Pneumoniae-Pipeline Insights, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆